-
Product Insights
Human Immunodeficiency Virus (HIV) Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
HIV Tests Pipeline Market Report Overview Human Immunodeficiency Virus (HIV) tests refer to the antigens, antibodies, and nucleic acid reagent tests performed for the detection of HIV type I. The HIV Tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...
-
Product Insights
HIV Point of Care (POC) Tests Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
HIV Point of Care (POC) Pipeline Market Report Overview Point of Care Testing (POC) is typically performed by non-laboratory personnel outside the clinical laboratory close to where the patient is receiving care. The results obtained from such tests are used for clinical decision-making. The HIV Point of Care (POC) pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein...
-
Product Insights
NewFluxergy LLC Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Fluxergy LLC Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Fluxergy LLC (Fluxergy) is a portable platform that consolidates laboratory testing to one device. The company tries to make laboratory testing accessible everywhere. Fluxergy is headquartered in Irvine, California, the US. GlobalData's Medical Devices company profile report, “Fluxergy LLC Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products. This company profile...
-
Product Insights
COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) are used to amplify and detect the specific nucleic acid sequences of SARS-CoV-2 virus at the point-of-care. The COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) pipeline market research report provides comprehensive information about the COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Moreover, the report...
-
Product Insights
Bacteriology Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Bacteriology Rapid Tests & POC comprises rapid test kits intended for rapid diagnosis, with immediate results, through immuno assays for Chlamydia, H. pylori, Streptococci, and Syphilis. The Bacteriology Rapid Tests & POC pipeline market research report provides comprehensive information about the Bacteriology Rapid Tests & POC pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Retrovirus Rapid Tests and POC – Medical Devices Pipeline Assessment, 2020
Retrovirus Rapid Tests are the diagnostic tests used for rapid diagnosis, with immediate results to detect the antigen/antibody of HIV1, HIV 2 (human immunodeficiency virus) and HTLV I, HTLV II (human T-cell lymphotropic virus) viruses. GlobalData's Medical Devices sector report, “Retrovirus Rapid Tests & POC-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Retrovirus Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are...
-
Sector Analysis
United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
GlobalData’s “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on: • Annualized market...